Smruthi Organics receives cGMP approval from USFDA

Smruthi Organics Ltd has announced that the Company's manufacturing facility located at Plot No A-27, MIDC, Chincholi, Solapur has been approved for current good manufacturing practices (cGMP) by the United Status Food and Drug Administration (USFDA). This compliance with cGMP authorizes the sale of the Company's products to the Lucrative United State markets.

This accreditation has strengthened the Company's position as a supplier of high quality products manufactured using high operational standards. Owing to the global reputation and credibility of the USFDA approval, this accreditation will have a substantial impact on the Company's marketing capabilities in regulated markets other than the United States as well.

The stock closed the day at Rs.60.20, down by Rs.4.40 or 6.81%. The stock hit an intraday high of Rs.60.20 and low of Rs.60.20. The total traded quantity was 50 compared to 2 week average of 755.

Source : Equity Bulls

Keywords